Skip to main content
. 2022 Oct 22;74:111–121. doi: 10.1016/j.pcad.2022.10.004

Table 3A.

Role of CMR in patients with COVID-19 myocarditis.52,92, 93, 94, 95, 96, 97, 98, 99

Author Total COVID +/ underwent CMR Myocarditis + Cardiac markers CMR findings Conclusion
Daniels et al. 1597/1597 37 Troponin elevation, ECG changes Increased T1/T2, and LGE 7.4-fold increased detection of myocarditis via MRI
Hendrickson et al. 137/5 0 Troponin elevation, coronary artery ectasia Unremarkable NA
Clark et al. 59/59 2 Normal Increase T1/T2, and LGE 3% prevalence of myocarditis in COVID +
Starekova et al. 145/145 2 Troponin elevation Increased T2, and LGE 1.4% prevalence of myocarditis in COVID + patients
Martinez et al. 789/27 3 Troponin elevation, ECG/echo changes Increased T2, LGE 0.4% prevalence of myocarditis in COVID +
Brito et al. 48/48 0 ECG changes and troponin elevation Pericardial LGE NA
Vago et al. 12/12 0 NA No Involvement NA
Malek et al. 26/26 0 Normal cardiac biomarkers 5 patients with borderline myocardial edema NA
Rajpal et al. 26/26 4 Normal cardiac biomarkers and ECG Increased T2 and LGE 0.15 % prevalence of myocarditis in COVID +